The most powerful thing an investor can do is embrace the idea that they don't know what the future holds.
There high-growth dividend stocks will be here over the long haul.
Think you can own big tech? You might just get an 'F' for that. Here's what will get you on the other side of this year.
A limited rally cooled some of the negativity on the market, but guess what's going to hit the fan soon?
Here's where nimble traders could probe the long side.
Let's check the charts on this biotechnology stock and see if it still has a prayer.
Traders should remain patient.
The next six months can't be worse than the first six, can they?
A look at the Russell indexes shows that value stocks suffered in the first six months of 2022 but not nearly as much as growth issues.
Let's check the charts and indicators.
MU reported earnings Thursday night and the guidance was shocking.
Keep in mind that no matter how much a stock has fallen, it can always go lower, and it appears these four stocks could prove that point.
The shares of the biotech company appear to be finding a bottom but could use more sideways action to create a better base.
Here's our current price target.
A key goal is to keep from losing money while the current bear runs its course, and don't count on positive seasonality leading to the Fourth of July.
As the second half of 2022 begins, keep this quarter of observations in mind.
The stock of the life sciences company has found buying interest at a key support level.
Just don't call it a handover - Chinese President Xi Jinping has been on a whistle-stop tour of Hong Kong, which we're now told never belonged to the British.
Plus, disappointing personal spending figures and an explanation of how the Fed views inflation (hint: it isn't how you view it).
Let's look at the incredible value of Roth conversions, during trying times.
Commodities like gas came down and people finally noticed. Let's check on that diesel, 30-year bonds and more.
After an ugly day of bear market trading, beware of what could hide ahead on Friday.
We're checking the charts and indicators on Ventas, owner of senior housing and medical facilities.
The Ionic Inflation Protection exchange-traded fund, the latest such ETF to hit the market, offers direct exposure to the consumer price index.
The first half of this year has been ugly. But we could have seen what would happen to Netflix, Tesla and Meta...
Plus, why a report about an Apple 5G modem setback sounds believable.
Buyers of the shares are becoming more aggressive.
These stocks are priced for an industry-wide calamity, but how realistic is that considering their customer base?
Here's what traders looking to go long GIS could do.
Is this a buying opportunity or the start of a deeper decline?